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Abstract
The eukaryotic cell membrane possesses numerous complex functions, which are essential for life. At this, the composition
and the structure of the lipid bilayer are of particular importance. Polyunsaturated fatty acids may modulate the physical
properties of biological membranes via alteration of membrane lipid composition affecting numerous physiological
processes, e.g. in the immune system. In this systematic study we present fatty acid and peptide profiles of cell membrane
and membrane rafts of murine macrophages that have been supplemented with saturated fatty acids as well as PUFAs from
the n-3, the n-6 and the n-9 family. Using fatty acid composition analysis and mass spectrometry-based peptidome profiling
we found that PUFAs from both the n-3 and the n-6 family have an impact on lipid and protein composition of plasma
membrane and membrane rafts in a similar manner. In addition, we found a relation between the number of bis-allyl-
methylene positions of the PUFA added and the unsaturation index of plasma membrane as well as membrane rafts of
supplemented cells. With regard to the proposed significance of lipid microdomains for disease development and treatment
our study will help to achieve a targeted dietary modulation of immune cell lipid bilayers.
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Introduction
In the last decade the traditional fluid mosaic model of the
plasma membrane as introduced 1972 by Singer and Nicholson
[1] has been extended to the lipid raft hypothesis [2]. According to
this structurally and functionally distinct domains can be
distinguished within the cell membrane due to their specific lipid
compositions [2]. In a Keystone Symposium on Lipid Rafts and
Cell Function the resulting microenvironments were defined as
‘‘small (10–200 nm), heterogeneous, highly dynamic, sterol- and
sphingolipid-enriched domains that compartmentalize cellular
processes’’ [3]. Small rafts were proposed to be stabilized via
protein-protein as well as protein-lipid interactions. [3]. A variety
of proteins have been shown to be enriched in membrane rafts
including GPI-anchored proteins, flotillin, receptor tyrosine
kinases and G protein-coupled receptors [4]. Taking the dynamic
nature of membrane domains into account the rafts have been
supposed to scaffold certain signaling molecules while excluding
others and thus function as a unique signaling platform [5]. In fact,
raft protein interaction is discussed to be central to biological
information transmission [6]. Further cellular processes membrane
domains have been implicated include membrane trafficking and
molecular sorting [7].
A range of macrophage functions interrelate with membrane
rafts. This includes endotoxin-mediated activation, phagocytosis
and MHCII-mediated antigen presentation [8,9]. Moreover, the
domains have been identified to play an important role in infection
biology [10]. It has been shown that a wide variety of pathogens
target rafts to invade host cells [10]. Likewise, bacterial toxins have
been demonstrated to enter cells via certain toxin-associated
receptors which are concentrated in membrane rafts [11].
Stimulation of RAW264.7 macrophages with LPS has been
described to result in a selective recruitment and activation of
proteins, e.g. proteasome subunits, in the membrane rafts [12].
Polyunsaturated fatty acids (PUFAs) are known to affect
numerous physiological processes being implicated in cardiovas-
cular, neurological and immune function as well as cancer [13,14].
Due to their pleiotropic effects on mammalian physiology a base
mode of action common to all cells has been postulated [14]. This
functional link may be the modulation of the physical properties of
biological membranes via alteration of membrane lipid composi-
tion [14]. In fact, changes in the fatty acid composition of immune
cell membranes have been shown to exert impact on phagocytosis,
T cell signaling as well as antigen presentation [15]. Due to the
significance of lipid interactions for the formation of membrane
domains, PUFAs have been speculated to perturb structure,
organization and function of rafts [11]. Moreover, domain
structure and composition have been hypothesized to directly
reflect biochemical and physiological processes [16]. Besides,
studies concerning the effects of PUFAs from the n-3 family, as
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immune cell function proposed a selective displacement of
acylated proteins from membrane rafts by virtue of a modified
raft lipid environment [11].
In this systematic study we present fatty acid and peptide
profiles of plasma membrane and rafts of macrophages from the
murine cell line RAW264.7 that have been supplemented with
saturated fatty acids as well as PUFAs from the n-3, the n-6 and
the n-9 family.
Results
Fatty acid composition in plasma membrane and
membrane rafts of RAW264.7 cultured in basic medium
Distinct differences in the fatty acid composition of plasma
membrane and membrane rafts from RAW264.7 cultured in basic
medium could be seen. In the plasma membrane the distribution
of the fatty acid families was 2.5% n-3, 5.6% n-6, 27.0% n-7,
28.7% n-9 and 36.2% saturated (Table 1). In the rafts the
proportion of the fatty acid families was as follows: 0.2% n-3, 3.3%
n-6, 24.7% n-7, 50.0% n-9, 21.8% saturated (Table 2). Of note,
the only detectable n-3 fatty acid in the membrane rafts was
C20:5n3 (EPA). The differences in the fatty acid profiles of the two
membrane domains were also reflected by the Methylene Bridge
Index (MBI) which was about 3 times greater for plasma
membrane than for membrane rafts (Table 1, Table 2). Fatty
acids identified to be abundant in both plasma membrane and
membrane rafts were C18:1n9 (oleic acid), C18:1n7 (vaccenic
acid), C16:1n7 (palmitoleic acid), C18:0 (stearic acid), C16:0
(palmitic acid) and C14:0 (myristic acid) (Table 3).
Fatty acid composition of plasma membrane and
membrane rafts of RAW264.6 cultured in PUFA
supplemented medium
Supplementation of culture medium with the n-3 PUFA LNA
(C18:3n3), EPA (C20:5n3) and DHA (C22:6n3) respectively
resulted in an increase in the content of n-3 fatty acids in both
plasma membrane and membrane rafts (Table 1, Table 2). This
rise was more pronounced for membrane rafts than for plasma
membrane leading to an approaximation in n-3 PUFA between
the two membrane domains (Table 1, Table 2). Fatty acids
detected to be significantly enriched in both plasma membrane
and membrane rafts were C22:5n3 (docosapentaenoic acid) for
LNA supplementation, C20:5n3, C22:5n3 and C22:6n3 for EPA
supplementation as well as C22:6n3 for DHA supplementation
(data not shown). Further n-3 fatty acids detectable in plasma
membrane as well as membrane rafts of n-3 PUFA supplemented
cells included C18:3n3, C20:3n3 (eicosatrienoic acid), C20:4n3
(eicosatetraenoic acid), C20:5n3, C22:5n3 and C22:6n3 (data not
shown). Besides, there was a decrease in the content of n-7 and n-9
monounsaturated fatty acids (Table 1, Table 2) mainly C18:1n7
(vaccenic acid) and C18:1n9 (oleic acid). The enrichment in n-3
PUFA content was connected with a rise of the MBI of both
membrane domains (Table 1, Table 2). Compared to RAW264.7
cultured in basic medium the calculated MBI of the plasma
membrane increased by factor 3 (LNA supplementation) to 4.4
(DHA supplementation) (Table 1, Table 2). For membrane rafts
an increase by factor 7.1 (LNA supplementation) to 12.4 (DHA
supplementation) was observed (Table 1, Table 2).
Enrichment of the culture medium with PUFAs of the n-6
family (LA (C18:2n6), c-LNA (C18:3n6), AA (C20:4n6)) resulted
in a rise in the content of n-6 fatty acids in plasma membrane as
well as membrane rafts (Table 1, Table 2). For both membrane
domains an increase of about 2.5 times could be detected (Table 1,
Table 2). Significantly enriched fatty acids in plasma membrane
and membrane rafts include C18:2n6 and C20:4n6 for LA
supplementation, C18:3n6, C20:3n6 (dihomo-gamma-linolenic
acid), C20:4n6 and C22:4n6 (docosatetratenoic acid) for c-LNA
supplementation as well as C20:4n6 and C22:4n6 for AA
supplementation. In addition to the rise in n-6 PUFAs, a decrease
in the content of n-7 and n-9 monounsaturated fatty acids (in
particular C16:1n7 (palmitoleic acid) and C18:1n7 (vaccenic acid))
was observed in plasma membrane and membrane rafts (Table 1,
Table 2). Furthermore, n-6 PUFA enrichment was connected with
a significant increase in MBI of the cells (plasma membrane: 2.1
times with LA supplementation to 3.0 times with AA supplemen-
tation; membrane rafts: 3.1 times with LA supplementation to 7.0
times with c-LNA supplementation; Table 1, Table 2).
Supplementation of the culture medium with the n-9 fatty acid
oleic acid (C18:1n9) as well as the saturated fatty acids palmitic
acid (C16:0) and stearic acid (C18:0) resulted in only marginal
modifications in the fatty acid composition of plasma membrane
and membrane rafts (data not shown).
Peptide profiles of plasma membrane and membrane
rafts
Peptide profiles of plasma membrane and membrane rafts from
RAW264.7 cultured in basic medium were found to resemble each
other (Table 4). However, eight peaks with m/z 1165, 1390, 2378,
4286, 5008, 7771 and 9108 were solely detected in the plasma
membrane (Table 4). For membrane rafts no such marker peaks
could be identified.
Supplementation of RAW264.7 with PUFA was found to have
only slight effects on the peptide profiles of both plasma membrane
Table 1. Fatty acid patterns [nmol/mg protein] and MBI in plasma membrane of PUFA supplemented cells.
Basic medium LNA EPA DHA LA c-LNA AA
n-3 53.4617.1
a 324.06220.9
a 388.3620.4
c 231.2616.8
b 48.2611.1
a 33.164.2
a 42.5621.1
a
n-6 119.4639.9
a 113.2662.9
a 77.266.8
a 55.164.4
b 302.9640.8
c 251.3638.2
c 315.8639.8
c
n-7 572.7668.3
a 415.16132.5
a 531.9621.4
a 355.9619.6
b 413.8660.4
b 360.0653.0
b 319.4655.5
b
n-9 607.46218.6
a 504.9683.8
a 276.9668.0
b 164.1612.5
c 375.2695.0
a 208.9615.2
b 467.66190.5
a
saturated 766.36130.2
a 764.46125.6
a 1136.0663.4
b 514.3654.8
c 698.7690.2
a 719.56280.7
a 722.46362.7
a
MBI 21.365.2
a 63.5636.2
a 74.065.0
c 93.564.9
d 44.064.1
b 49.6611.2
b 64.6614.9
b
Fatty acid patterns [nmol/mg protein] and Methylene Bridge Index (MBI) in plasma membrane of RAW264.7 cultured for 72h in basic medium as well as in medium
supplemented with 15 mmol/l alpha-linolenic acid (LNA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), linoleic acid (LA), gamma-linolenic acid (c-LNA) and
arachidonic acid (AA) respectively. Data are mean6S.D. (n=6). Superscript letters across a row denote significant differences.
doi:10.1371/journal.pone.0024066.t001
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1390, 1461, 1516, 1575, 3066 and 7771, and in membrane rafts
peaks with m/z 1015, 1043, 1059, 1087, 1115 and 1461 turned out
to be sensitive to the fatty acid composition of the membrane
compartment (Table 4).
An in silico search against SwissProt database using the TagIdent
tool from ExPASy Proteomics Server (error tolerance: 350 ppm,
taxonomy: Mus musculus) did not result in a reliable identification of
the peaks mentioned.
Discussion
Eukaryotic cell plasma membrane not only forms a selective
barrier controlling the transport of molecules inside and outside
but also regulates cell communication. Further cellular processes
the lipid bilayer is involved include proliferation, differentiation,
secretion, migration, invasion and phagocytosis to name a few. Of
note, the composition and the structure of the plasma membrane is
known to play a key role in these processes [10].
According to our current state of knowledge lipids actively
influence the dynamics and the protein organization of mem-
branes [10]. In particular, lipids are of importance in the
formation of membrane rafts. Membrane rafts are discussed as
control points of plasma membrane dependent biological events
such as signaling [5,7], sorting and trafficking [7,17], cell adhesion
[18], migration [18], pathogen entry [10,11,19] and immune
response [11,20]. Moreover, rafts have been suggested to play
critical roles in many human diseases [21–23]. Alterations in
membrane lipid composition have been shown to shift raft
structure and function [21,22]. The dietary modulation of
membrane rafts therefore is assumed as a promising treatment
for membrane associated diseases [22,24].
Supplementation of the culture medium with PUFAs from the
n-3 and the n-6 family resulted in significant alterations in the fatty
acid composition of both plasma membrane and membrane rafts
of RAW264.7 macrophages. Of note, the PUFAs added to the
culture medium were not only incorporated but also metabolized
leading to a significant increase of their desaturation and
elongation products. This was accompanied by a decrease in the
content of monounsaturated fatty acids of the n-7 and the n-9
family in plasma membrane as well as in membrane rafts. The
enhanced proportion of polyunsaturated fatty acids brought about
an increase of the MBI. The MBI is defined as the mean number
of bis-allyl-methylene positions per fatty acid contained in the
membrane domains. It is calculated by multiplying the number of
bis-allyl-methylene positions contained in each fatty acid methyl
ester species by its respective mole fraction and summed for all
fatty acids present [25]. The higher the MBI, the higher the un-
saturation of the membrane lipids. Remarkably, depending on the
fatty acid added both in plasma membrane and in membrane rafts
there was a significant difference in MBI gained with DHA
supplementation resulting in the highest and LA supplementation
resulting in the lowest MBI. Thus, there is a relation between the
number of methylene bridges of a PUFA supplemented and the
dimension of un-saturation of cellular membranes. However, for
all fatty acids tested the MBI of membrane rafts was lower
compared to the MBI of plasma membrane.
So far, investigations concerning the effects of PUFA supple-
mentation on membrane rafts lipid composition have been focused
on the n-3 fatty acids EPA and DHA [5,26–29]. At this, EPA and
DHA have been identified to modify membrane rafts character-
ized by an enrichment of the PUFAs added and a decrease of
monounsaturated fatty acids, which is connected with alterations
in raft size, stability and distribution [5,26–29]. Thus, our data are
in accordance with these previous results. Moreover, our study
provide evidence that these effects are not exclusive to long-chain
polyunsaturated fatty acids of the n-3 family but are also true of
shorter chain n-3 fatty acids such as LNA as well as for PUFAs
from the n-6 family such as LA, c-LNA and AA. Overall, these
findings hint towards the impact of dietary fatty acids of both the
n-3 and the n-6 family on the biochemical make up of lipid
bilayers.
Noteworthy, the phagocytic activity of neutrophils and
monocytes has been shown to depend on the membrane fatty
Table 2. Fatty acid patterns [nmol/mg protein] and MBI in membrane rafts of PUFA supplemented cells.
Basic medium LNA EPA DHA LA c-LNA AA
n-3 4.3610.5
a 279.06318.1
a 200.6639.5
b 154.269.2
b n.d. n.d. n.d.
n-6 79.669.6
a 135.0673.5
a 79.0611.3
a 89.0634.0
a 251.36116.2
b 179.2637.0
b 196.1645.0
b
n-7 604.7681.2
a 382.96121.6
b 425.6698.4
b 303.8641.6
b 419.46130.0
a 209.9653.0
c 264.0644.3
b
n-9 1224.06505.7
a 1403.06500.6
a 480.0641.8
b 407.56240.0
b 1089.06133.8
a 553.36276.3
a 1458.06169.0
a
saturated 534.4652.4
a 402.96220.9
a 818.46349.4
a 388.16482.0
a 385.66139.8
a 100.6634.0
c 251.6664.9
b
MBI 6.765.8
a 44.6642.0
a 50.0611.1
bc 78.4635.4
c 20.668.2
b 46.8628.1
b 23.465.5
b
Fatty acid patterns [nmol/mg protein] and Methylene Bridge Index (MBI) in membrane rafts of RAW264.7 cultured for 72h in basic medium as well as in medium
supplemented with 15 mmol/l alpha-linolenic acid (LNA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), linoleic acid (LA), gamma-linolenic acid (c-LNA) and
arachidonic acid (AA) respectively. Data are mean6S.D. (n=6). Superscript letters across a row denote significant differences. n.d. =below detection limit.
doi:10.1371/journal.pone.0024066.t002
Table 3. Fatty acids [nmol/mg protein] dominating in plasma
membrane and membrane rafts of cells cultured in basic
medium.
Plasma membrane Membrane rafts
C18:1n9 1115.06498.6
a 506.56205.0
a
C18:1n7 377.4674.4
a 331.1648.0
a
C16:1n7 217.3611.4
a 203.0618.2
a
C18:0 128.9639.5
a 178.7632.9
a
C16:0 156.3641.0
a 434.66127.5
b
C14:0 126.4611.5
a 97.5611.9
b
Fatty acids [nmol/mg protein] dominating in plasma membrane and membrane
rafts of RAW264.7 cultured for 72h in basic medium. Data are mean6S.D. (n=6).
Superscript letters across a row denote significant differences. C18:1n9: oleic
acid; C18:1n7: vaccenic acid; C16:1n7: palmitoleic acid; C18:0: stearic acid; C16:0:
palmitic acid; C14:0: myristic acid.
doi:10.1371/journal.pone.0024066.t003
Macrophage Membrane Lipid and Peptide Composition
PLoS ONE | www.plosone.org 3 August 2011 | Volume 6 | Issue 8 | e24066Table 4. Peptide profiles of plasma membrane and membrane rafts.
Plasma membrane
(m/z)
Membrane rafts
(m/z) Notions
1015 1015 Sensitive to fatty acid composition of membrane rafts
1043 1043 Sensitive to fatty acid composition of membrane rafts
1052 1052
1059 1059 Sensitive to fatty acid composition of membrane rafts
1067 1067
1073 1073
1083 1083
1087 1087 Sensitive to fatty acid composition of membrane rafts
1115 1115 Sensitive to fatty acid composition of membrane rafts
1131 1131
1147 1147
1165 Unique peak for plasma membrane
1190 1190
1200 1200
1263 1263
1275 1275
1280 1280
1291 1291
1310 1310
1334 1334
1385 1385
1390 Unique peak for plasma membrane; Sensitive to fatty acid composition of plasma membrane
1408 1408
1448 1448
1461 1461 Sensitive to fatty acid composition of plasma membrane and membrane rafts
1511 Unique peak for plasma membrane
1516 1516 Sensitive to fatty acid composition of plasma membrane
1534 1534
1552 1552
1575 1575 Sensitive to fatty acid composition of plasma membrane
1618 1618
2211 2211
2378 Unique peak for plasma membrane
2868 2868
2909 2909
2995 2995
3012 3012
3035 3035
3050 3050
3066 3066 Sensitive to fatty acid composition of plasma membrane
3175 3175
3192 3192
3217 3217
3779 3779
3796 3796
3820 3820
3853 3853
3906 3906
Macrophage Membrane Lipid and Peptide Composition
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negatively correlated to saturated fatty acid content and to be
positively correlated with unsaturated fatty acid content whether
n-3 PUFAs or n-6 PUFAs [15]. This effect is discussed to be in
part due to alterations in receptor expression, but primarily to
origin in the physical nature of the membrane of the phagocytes
[15]. The incompatibility between the highly flexible, very long
chain PUFAs and the rigid sterol moiety of cholesterol is well
known [14,30]. In fact, a growing number of studies verify the
tremendous impact of PUFAs on the physical properties of
membranes. This includes membrane permeability [31], mem-
brane elasticity and curvature strain [32–34] thereby modulating
membrane fusion [35], vesicle formation [36], lateral lipid
segregation [37] and flip-flop mechanisms [38].
Moreover, changes in membranes properties due to altered lipid
composition are proposed to affect the organization and
interactions between lipids and proteins [14]. PUFA incorporation
into membrane lipids of a Jurkat T cell line as well as COS-1 cells
has been shown to result in a selective displacement of the Src
family kinases Lck, Fyn and LAT from membrane rafts [26,39–
41]. Further membrane-associated proteins known to be affected
by PUFA enrichment of the lipid bilayer include the signaling
proteins Ras, Akt and Her-2/neu [24] as well as the immunogenic
receptors TLR4 [42], IL-2 and FcR [28,43]. Treatment of
antigen-presenting cells with EPA or DHA has been found to
decrease MHCII expression and MHCII-dependent antigen
presentation by the monocytes and dendritic cells in vitro [15].
Altogether, these data underline the importance of membrane
lipid composition for cell communication and immune defense.
Actually, two possible routes are discussed by which PUFA may
interfere with protein targeting to membrane rafts. On the one
hand the PUFAs have been shown to inhibit protein acylation with
saturated acyl moieties [41]. On the other hand supplementation
of cells with PUFA results in the aforementioned alteration in
membrane lipid environment. Transmembrane as well as acylated
proteins are believed to directly interact with cholesterol-
sphingolipid complexes by means of their transmembrane amino
acids and their saturated acyl moieties respectively [14,44].
Changes in the lipid composition of the membrane therefore
may have a profound impact on the micro domain localization of
proteins.
To obtain deeper insights into the interactions between lipids
and proteins we performed a peptide profiling analysis of plasma
membrane and membrane rafts of PUFA supplemented
RAW264.7 macrophages. Peptide profiling can be accomplished
in a variety of biological samples, i.e. tissues, cells, organelles,
blood samples and supramolecular complexes, such as lipid
bilayers [45]. To minimize any sampling-related disturbances
the samples were collected, stored and processed according to a
feasible and highly standardized pre-analytic protocol [46]. The
Plasma membrane
(m/z)
Membrane rafts
(m/z) Notions
3922 3922
3947 3947
3979 3979
3996 3996
4020 4020
4286 Unique peak for plasma membrane
4583 4583
4709 4709
4725 4725
4751 4751
4968 4968
4983 4983
5008 Unique peak for plasma membrane
6116 6116
6175 6175
6214 6214
6231 6231
6256 6256
6288 6288
6304 6304
6377 6377
7112 7112
7771 Unique peak for plasma membrane; Sensitive to fatty acid composition of plasma membrane
9108 Unique peak for plasma membrane
Peptide profiles of plasma membrane and membrane rafts of RAW264.7 cultured for 72h in basic medium. Peptidome separation was done using the CLINPROT
profiling purification kit from Bruker Daltonics (Billerica, USA) by means of magnetic particles with magnetic bead-hydrophobic interaction (MB-HIC C8).
doi:10.1371/journal.pone.0024066.t004
Table 4. Cont.
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RAW264.7 macrophages were found to highly resemble each
other. Nevertheless, eight peaks unique for plasma membrane
could be detected. Unfortunately, at present it was not possible to
reliably identify the mentioned peaks by means of an in silico search
in a leading protein database. The incorporation of PUFAs into
the lipid bilayer was observed to have slight effects on the overall
peptide profile of both plasma membrane and membrane rafts of
RAW264.7 macrophages. Indeed, several peaks sensitive to the
fatty acid composition of both plasma membrane and membrane
rafts could be seen. The ability of PUFAs to influence the lateral
organization of membrane micro domains in situ, however,
remains unclear.
Taking together, using the murine macrophage cell line
RAW264.7 as a model system we identified PUFAs from both
the n-3 and the n-6 family to impact lipid and protein composition
of plasma membrane and membrane rafts in a similar manner. In
addition, we found a relation between the number of bis-allyl-
methylene positions of the PUFA added and the un-saturation
index of plasma membrane as well as membrane rafts of
supplemented cells. The concentrations of free fatty acids tested
in our study match physiological conditions [47], and the
membrane preparation was performed detergent-free thus under-
lining the relevance of the gained results. With regard to the
proposed significance of lipid micro domains for disease
development and treatment our systematic study will help to
understand dietary modulation of immune cell lipid bilayers.
Materials and Methods
Materials
All chemicals and reagents were obtained from Sigma-Aldrich
(Taufkirchen, Germany) unless noted otherwise. Cell culture flasks
were purchased from Greiner Bio-One (Frickenhausen, Germany).
HEPES (25 mmol/L)-buffered RPMI 1640 culture medium
containing 300 mg/L L-glutamine was acquired from PAA
Laboratories GmbH (Co ¨lbe, Germany).
Cell culture
The permanent mouse monocyte/macrophage cell line
RAW264.7 (ATCC number TIB-71) was used. The RAW264.7
cells were cultured in RPMI 1640 medium supplemented with
4.5 g/L glucose and 5% FCS (basic medium). The fatty acids
alpha-linolenic acid (LNA), eicosapentaenoic acid (EPA), docosa-
hexaenoic acid (DHA), linoleic acid (LA), gamma-linolenic acid (c-
LNA), arachidonic acid (AA), oleic acid, palmitic acid or stearic
acid (all Biotrend, Ko ¨ln, Germany) were included in the culture
medium in concentrations of 15 mmol/L using ethanol as a vehicle
(0.2% v/v final ethanol concentration). Cells were incubated in 75
cm
2 cell culture flasks at a density of 1610
6 cells/mL for 72 h at
37uC and 5% CO2 in a humidified atmosphere.
Detergent-free preparation of membrane rafts and
plasma membrane
Preparation of membrane rafts and plasma membrane was
carried out detergent-free per density gradient ultracentrifugation
by the method introduced by Macdonald and Pike [48] with slight
modifications [49]. 2610
7 cells were suspended in isolation buffer
(20 mM Tris-HCl, pH 7.8, 250 mM sucrose, 1 mM CaCl2,
1 mM MgCl2, supplemented with 0.2% protease inhibitor cocktail
set III (Calbiochem, Darmstadt, Germany)) and homogenized by
20 passages through a 22G syringe needle. After centrifugation
(1000 g for 10 min) aspirated supernatants were mixed with an
equal volume (2 mL) of separating buffer (120 mM Tris-HCl,
pH 7.8, 250 mM sucrose containing 50% OptiPrep) and placed in
the bottom of a 12 mL centrifuge tube. An 8 mL gradient of 0%
to 20% OptiPrep was poured on top of the lysate. Gradients were
centrifuged for 90 min at 52000 g using an SW-41 rotor (Beckman
Coulter Incorporation, Fullerton, USA) by means of a Sorvall
Discovery 90 SE ultracentrifuge (Hitachi, Tokio, Japan). Subse-
quently, gradients were fractionated into 12 1 mL fractions from
the top to the bottom. Total protein in each fraction was
determined using the Roti
HQuant assay kit (Roth, Karlsruhe,
Germany). Fractions were analyzed by Western blot for the
presence of the raft marker EGF receptor [4,48,50–52] (using anti-
EGFR antibody, Biolegend, Diego, USA) as well as the plasma
membrane marker transferrin receptor [8,12,48] (using anti-
TFRC antibody, GeneTex, Irvine, USA). EGF receptor was found
to be enriched in fraction 1 (= membrane raft fraction),
transferrin receptor was found to be enriched in fraction 7 (=
plasma membrane fraction).
Fatty acid composition analysis
Fatty acid composition was analyzed by lipid extraction and
subsequently gas chromatography [53]. The membrane lipids
were trans-esterified with 500 mL methanolic HCl, 250 mLn -
hexane and 500 mL internal standard (0.8 mg Di-C17-phospha-
tidylcholine in 1 mL methanol with 0.2% Butylhydroxytoluol as
antioxidant). After cooling-off, 500 mL n-hexane and 1 mL aqua
dest. were added. The upper hexane phase was evaporated with
nitrogen. The fatty acid methylesters (FAME) were taken up in
60 mL n-hexane. An aliquot of 1 mL was injected on-column on a
Varian CP 3800 gas chromatograph (Varian, Darmstadt,
Germany) equipped with an Omegawax TM 320 column
(0.32 mm internal diameter, 30 m length) (Supelco, Bellefonte,
USA). The column temperature was 200uC. Based on the ratio of
a fatty acid (weight %) detected by gas chromatography and the
number of its bis-allyl-methylene positions the Methylene Bridge
Index (MBI) was calculated [25].
Peptidome profiling
The isolation, concentration and purification of peptides from
the prepared samples of membrane rafts and plasma membrane
was done using the Profiling kit MB-HIC 8 (Bruker Daltonics,
Billerica, USA) by means of magnetic particles with defined
surface functionalities (magnetic bead-hydrophobic interaction).
The workflow of the peptidome separation procedure includes the
binding of the sample to the magnetic beads, the washing of the
sample bound to the magnetic beads and the elution of the sample
bound to the magnetic beads. The magnetic bead preparation was
processed in an automated one-step procedure by the CLIN-
PROT liquid handling robot (Bruker Daltonics, Billerica, USA)
according to the manufactures instructions. A linear MALDI-TOF
mass spectrometer (Autoflex I, Bruker Daltonics, Billerica, USA)
was used for the peptidome profiling. Mass calibration was done
using the standard calibration mixture of peptides and proteins in
a mass range of 1 to 10 kDa. Mass spectra were recorded and
processed using the AutoXecute tool of the flexControl acquisition
software (version 2.0; Bruker Daltonics, Billerica, USA). Each
sample was processed 4-fold to improve data reproducibility.
Bioinformatic data analysis was performed by means of the
ClinPro Tools (CPT) 2.0.365 Software (Bruker Daltonics, Bill-
erica, USA). The workflow started by loading of two selected
classes (e.g. unsupplemented and supplemented plasma membrane
fractions, unsupplemented and supplemented membrane rafts
fractions, plasma membrane and membrane rafts fractions of
equally supplemented cells). The software package used includes
an automated raw data pretreatment workflow, comprising
Macrophage Membrane Lipid and Peptide Composition
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normalization of spectra according to the total ion count, an
alignment of peaks with a signal-to-noise ratio (S/N) .3t o
prominent peaks with S/N .100 and a peak-picking procedure
resulting in peaks defined as dynamic m/z ranges. Savitzky-Golay
smoothing was deactivated to avoid the blurring of peaks (CPT
manual version 2.0). Peak statistics were done using Welch `s t test
without multiple testing correction. Finally, the software provides a
list of peaks sorted along the statistical difference between two
classes [46].
Statistical analysis
Data are shown as means 6 standard deviation (S.D.). Two-
way analysis of variance followed by unpaired Students t test was
used to identify significant differences between means. The
statistical analysis was carried out by means of the program
GraphPad Prism 4 (GaphPad Software, La Jolla, USA). In all
cases, p,0.01 was assumed to indicate significant differences.
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